← Back to atlasFullscreen ↗Fullscreen ↗
L445V
Category 4 — Stable Fold, Function DisruptedConflictingTransmembrane · predictedEditorialLeucine → Valine at position 445 · TM4 (427-447), helical transmembrane · WFS1 (Wolframin)
Leu→Val p445 TM4 AM=0.10 ddg=+0.32 pLDDT=84. ClinVar Conflicting evidence. Atlas mechanism: see structural analysis.
Interactive 3D Structure
Wild-type reference
Wild-type L445 — hydrogen bond to V441
DynaMut2 mutant · L445V
Mutant V445 — hydrogen bond to V441 lost (3 contacts lost)
Bond changes · DynaMut2 interaction analysis
3 lost2 gained4 preserved
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | V441 | V441 | Preserved |
| Hydrogen bond | — | T442 | Gained |
| Polar contact | V441 | V441 | Preserved |
| Polar contact | T442 | T442 | Preserved |
| Polar contact | S443 | S443 | Preserved |
| Polar contact | — | L447 | Gained |
| Van der Waals | V441 | — | Lost |
| Van der Waals | S443 | — | Lost |
| Hydrophobic | V441 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
DynaMut2 ΔΔG
0.32kcal/mol
Stabilising — mild
AlphaMissense
0.096
LBen
AlphaFold pLDDT
84
model confidence
Schema
Cat 4
Category 4 — Stable Fold, Function Disrupted
Clinical Evidence
ClinVar classificationConflicting classifications of pathogenicity
Review statuscriteria provided, conflicting classifications
Associated conditions(no specific conditions catalogued)
InheritanceConflicting ClinVar classifications.
Population frequency (gnomAD v4)Ultra-rare · AF 0.0060%
cDNA changec.1333C>G
ClinVar accessionVCV000349318
Last evaluated2025/09/02 00:00
Observed at very low frequency in gnomAD.
Structural Context
Position analysis: SER446 (2.5 Å), TYR444 (2.5 Å — partner of S443R), THR442 (3.8 Å). Near S443R cluster. The Atlas's neighbor extraction surfaces this variant's contacts.
Amino-acid chemistry
conservative volume reduction
Position in the protein
TM4 (427-447)
Druggability Assessment
Cat 4 — see structural prose. AlphaMissense below threshold (AM under-call class) but mechanism is structurally clear from neighbor analysis. Therapeutic strategy: site-directed at the contacts identified above.
Why this matters
TM4 cluster adjacent to S443R.
Therapeutic Strategy Handoff · prediction
Feed this card to Wolfram Intelligence
Download the L445V PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.
Download L445V PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.
UniProt Domain Annotation
Chain1–890 · Wolframin
Transmembrane427–447 · Helical